These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients. Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035 [TBL] [Abstract][Full Text] [Related]
8. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population. Demisch L; Gebhart P; Kaczmarczyk P; von der Mühlen H; Bochnik HJ Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472 [TBL] [Abstract][Full Text] [Related]
9. Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patients. Owen F; Bourne R; Crow TJ; Johnstone EC; Bailey AR; Hershon HI Arch Gen Psychiatry; 1976 Nov; 33(11):1370-3. PubMed ID: 791182 [TBL] [Abstract][Full Text] [Related]
11. Human platelet MAO in drug-free and medicated schizophrenic patients. Friedhoff AJ; Miller JC; Weisenfreund J Am J Psychiatry; 1978 Aug; 135(8):952-5. PubMed ID: 27104 [TBL] [Abstract][Full Text] [Related]
12. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252 [TBL] [Abstract][Full Text] [Related]
13. Platelet monoamine oxidase and clinical phenomenology of schizophrenia. Baron M; Gruen R; Levitt M; Kane J Psychiatry Res; 1984 Mar; 11(3):205-9. PubMed ID: 6587413 [TBL] [Abstract][Full Text] [Related]
14. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome. Mann J; Thomas KM Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192 [TBL] [Abstract][Full Text] [Related]
15. Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia. Demisch L; von der Mühlen H; Bochnik HJ; Seiler N Arch Psychiatr Nervenkr (1970); 1977 Dec; 224(4):319-29. PubMed ID: 606205 [TBL] [Abstract][Full Text] [Related]
16. Platelet MAO activity and personality characteristics. A study in schizophrenic patients and normal individuals. Gattaz WF; Beckmann H Acta Psychiatr Scand; 1981 May; 63(5):479-85. PubMed ID: 7315490 [TBL] [Abstract][Full Text] [Related]
17. Negative symptoms and platelet monoamine oxidase activity in male schizophrenic patients. Lewine RJ; Meltzer HY Psychiatry Res; 1984 Jun; 12(2):99-109. PubMed ID: 6591224 [TBL] [Abstract][Full Text] [Related]
18. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups. Wise CD; Bridge TP; Potkin SG; Wyatt RJ Psychiatry Res; 1979 Oct; 1(2):187-90. PubMed ID: 298348 [TBL] [Abstract][Full Text] [Related]
19. Platelet monoamine oxidase activity in schizophrenia: a review of the data. Wyatt RJ; Potkin SG; Murphy DL Am J Psychiatry; 1979 Apr; 136(4A):377-85. PubMed ID: 371419 [TBL] [Abstract][Full Text] [Related]
20. Platelet serotonin concentration and monoamine oxidase activity in unmedicated chronic schizophrenic and in schizoaffective patients. Joseph MH; Owen F; Baker HF; Bourne RC Psychol Med; 1977 Feb; 7(1):159-62. PubMed ID: 859953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]